|
|
Prof. Mohamed Al-Hajjaj, Consultant and Professor of Medicine
and Pulmonary Diseases. King Saud University &
King Khalid University Hospital
Prof. Al-Hajjaj, graduated from King Saud University Medical
College in 1981 and obtained The American board of Internal
Medicine in 1986, Certificate of Fellow of the Royal College of
Physician and Surgeons of Canada( FRCP (C ) in 1987 and The
American Board of Respiratory Diseases in 1988. He has been a
Professor of Medicine and Pulmonology since 2002. His research
interest is in the field of bronchial asthma and COPD. Professor
Al-Hajjaj has published more than 40 research papers in the
medical literature. Currently he is the head of Respiratory
Division, in the Medicine Department, College of Medicine, King
Saud University, and The chairman of the Saudi Thoracic Society. |
Name: Mohamed Saleh Al-Hajjaj
Date of
birth: February 1, 1957
Marital
status: Married with 3 children
Nationality: Saudi Arabian
Address:
Department of Medicine (38)
College of Medicine
King Saud University
P.O. Box 2925
Riyadh 11461
Saudi Arabia
E-mail : msalhajjaj@yahoo.com
QUALIFICATIONS:
MBBS King
Saud University
Riyadh, Saudi Arabia
June, 1981
ABIM
American Board of Internal Medicine
September, 1986
FRCP(C ) The
Royal College of Physician & Surgeons
of Canada , November, 1987
Respiratory American
Board of Respiratory Disease
Diseases
November, 1988
OTHER EXAMINATIONS AND QUALIFICATIONS:
CEE:
Canadian Evaluation Examination, 1982
ECFMG:
Certificate, 1982
LMCC:
Licentiate of the Medical Council of Canada, 1985
FLEX:
Federal License Examination (USA), 1985
PRESENT PROFESSIONAL STATUS:
Professor Respiratory Division, Department of
Medicine,
College of Medicine, King Saud University
Consultant Physician Internal
Medicine and Pulmonology
King Khalid University Hospital
Head
Respiratory Division, Dept of Medicine, KSU
Chairman Saudi
Thoracic Society
Part-time Consultant The Medical
Consultants Center
Pulmonologist Riyadh,
Saudi Arabia
PROFESSIONAL EXPERIENCE AND TRAINING:
June 1981 MBBS,
Riyadh University, Riyadh, Saudi Arabia
July 1981 – June 1982 Internship,
King Saud University,
Teaching Hospitals, Riyadh, Saudi Arabia
July 1982 – June 1983 Resident (SHO)
& Demonstrator of Medicine Dept.,
King Abdulaziz University Hospital, Riyadh,
Saudi Arabia
July 1983 – June 1986 Resident,
Department of Medicine, University of
Alberta Teaching Hospital, Edmonton,
Canada
July 1986 – June 1987 Pulmonary
Fellow, and Chief Pulmonary Resident,
University of Alberta, Edmonton, Canada
July 1987 – June 1988 Pulmonary
Fellow Research and Clinical work
(Tuberculosis Center), University of
British
Columbia, Vancouver, Canada
July 1988 – Oct. 1992 Assistant
Professor & Consultant Internist &
Pulmonologist, Department of Medicine,
King Saud University & King Khalid
University Hospital
Oct. 1992 – Oct. 2002 Associate
Professor, Consultant Internist &
Pulmonologist, Department of Medicine,
King Saud
University & King Khalid University Hospital
Oct. 2002 to date Professor,
Consultant Internist & Pulmonologist
Department of Medicine, King Saud
University & King Khalid University Hospital
Jan.2005
Chairman, Saudi Thoracic
Jan 2006 Head,
Respiratory Division, Dept of Medicine, KSU
CURRENT
PROFESSIONAL WORK:
(A). CLINICAL
As a consultant in internal
medicine and pulmonology, I supervise a team of physicians (2 interns, 2
residents, and 2 senior registrars) in diagnosis and management of
patients in the ward and in the clinic. As a pulmonologist, my work
also includes consultations, bronchoscopies, and PFT interpretation.
(B). ACADEMIC
Academic activities as a
University staff include extensive teaching for both undergraduate and
postgraduate students (Diploma, Arab Board and Fellowship), and
participation in Grand Rounds, Topic Updates and Examination Review
Sessions.
(C). MEDICAL RESEARCH
My main field of research is
pulmonary medicine including bronchial asthma and tuberculosis. I
participated in a national tuberculosis survey, (1988-1990) and another
tuberculosis research to study active tuberculosis cases in the Ministry
of Health (MOH) hospital. A major multicenter research was recently done
on asthma control test in Saudi Arabia.
ACADEMIC AND ADMINISTRATIVE EXPERIENCE:
(A).
DURING THE PERIOD OF TRAINING:
During training I was
frequently involved in teaching of medical students and junior medical
residents. Towards the end of my training period, I became the chief
resident in pulmonary medicine and participated in basic and clinical
research work.
(B). KING SAUD UNIVERSITY:
1.
Organizer for MED Course 332 and tutor of major
undergraduate course MED 431/432.
2.
Member of
Curriculum Committee of the Medicine Department.
3.
Member of the
Medical Records Committee at King Khalid University Hospital.
4.
Organizer of the
computer-based medical education programs
5.
Member of the
Committee for the Transfer to the annual teaching system.
6.
Coordinator of
interns rotation in the Medicine Department.
7.
Member of the
committee for Residency Training Program.
8.
Coordinator of
continuous education in the Respiratory Division.
9.
Program Director
of King Saud University Fellowship in Respiratory Disease.
10.
Coordinator of
the committee for establishment of the Saudi Board in Respiratory
Diseases.
11.
Head of the
scientific committee for the Saudi Board in Respiratory Diseases.
TEACHING EXPERIENCE:
Through the 5 years of training
in medicine and pulmonology, I had the responsibility of teaching
students, interns, and medical residents as well as supervising their
clinical work. Since July 1988, my responsibility included teaching of
medical students, interns Arab Board residents and King Saud University
Fellowship in Medicine and in Respiratory diseases, as well as
participating in all postgraduate teaching programs and courses besides
my clinical practice commitments. Currently I am the coordinator for
continuous education in the respiratory division, the program director
for KSU fellowship in Respiratory diseases, and the coordinator of the
committee for establishment of the National Saudi Board in Respiratory
Diseases.
MEMBERSHIP OF MEDICAL ORGANIZATIONS AND
ASSOCIATIONS:
1.
Fellow of the Royal College of Physicians of Canada.
2.
Member of the
American College of Physicians.
3.
Member of the
American College of Chest Physicians.
4.
Member of the
American Thoracic Society.
5.
Member of the
International Union Against Tuberculosis and Lung Diseases.
6.
Fellow of the
Academy of Chest Physicians and Surgeons of the American College of
Chest Physicians
7.
Member of the
Asian Pacific Society of Respiratory Diseases.
8.
Member and
regional representative of the Pan-Arab Thoracic Association.
9.
Member of the
Saudi Environmental Protection Society.
10.
Member of the
Saudi Thoracic Society.
11.
Head of the
founding Committee for the Saudi Thoracic Association.
12.
Member of the
Saudi Anti-Smoking Society.
13.
Member of the
National Tuberculosis Control Program Committee.
14.
Head of Saudi
Thoracic Society.
REVIEWER FOR MEDICAL JOURNALS:
1.
Saudi Medical
Journal (Riyadh Armed Forces Hospital)
2.
Annals of Saudi
Medicine (King Faisal Specialist Hospital)
3.
The Journal of
Family and Community Medicine
4.
Annals of
Thoracic Medicine.
5.
A referee for
academic promotions.
CONFERENCES AND SYMPOSIA PARPTICIPATED
IN/OR ATTENDED:
1.
Update in
Internal Medicine, Phoenix, USA 1983.
2.
Update in ICU.
Banff – Alberta, Canada 1984.
3.
Tuberculosis
Courses. Edmonton – Alberta, Canada 1985.
4.
Internal
Medicine: Advances. San Francisco, USA 1986.
5.
ATS Meeting. Las
Vegas, USA 1988.
6.
Board Review in
Pulmonary Diseases. Denver, USA, June 1988.
7.
ATL/ALA
Conference. Cincinnati, USA May 1989.
8.
Recent Advances
in Infectious Diseases Conference. Riyadh, Saudi Arabia, May 1990.
9.
Basic Immunology
in Clinical Medicine Symposium. Riyadh, Saudi Arabia, March 1990.
10.
The Fleischner
Society 20th Annual Symposium on Chest Diseases, Scottsdale,
Az, USA, April 1990.
11.
The 56th
Annual Scientific Assembly. Toronto, Canada. October 1990.
12.
The Fleishner
Society Annual Symposium, Tuson, Italy, 1993.
13.
The Clinical
Congress on Diseases of the Chest and the American College of Chest
Physician Annual Meeting. San Francisco, CA, USA 1996.
14.
Asthma Management
Symposium, Madrid, Spain, 1997.
15.
American College
of Chest Physician Conference (ACCP). Toronto, Canada, November 8-12,
1998.
16.
The 3rd
International Conference of the Arab Thoracic Association. Royal
Cultural Center, Jordan, 7-10 November 1999.
17.
15th
Asia Pacific Congress on Diseases of the Chest. Manila, Philippines,
December 5-8, 1999.
18.
World Congress on
Lung Health and 10th European Respiratory Society Annual
Congress in Florence 30 August – 3 September 2000.
19.
2nd
Mediterranean Congress, Beirut, Lebanon, 19-21 October 2000.
20.
The 4th
International Conference of the Arab Thoracic Association, Dubai, UAE,
November 2000.
21.
The 5th
International Conference of the Arab Thoracic Association, Tunis, 2001.
22.
The 6th
Pan Arab Conference in Syria 2002.
23.
New Trends in
Treatment of Bronchial Asthma, June 2003, Medina, SA.
And many more
ARTICLES PUBLISHED IN MEDICAL JOURNALS:
1.
Al-Majed SA,
Ashour M, El-Kassimi FA, Joharjy I, Al-Wazzan A, Al-Hajjaj MS, Vijay R.
Management of post-tuberculous complex
aspergilloma of the lung: role of surgical resection. Thorax 1990; 45:
840-849.
2.
Al-Kassimi FA,
Hawass ND, Mahmoud K, Al-Majed SA, Al-Hajjaj MS. Silicosis of the lung
in Saudi Arabia – Role of traditional occupations and environmental
factors. Saudi Med J 1991; ;12 (4): 384-388.
3.
Al-Hajjaj MS.
Ectopic intratracheal thyroid
presenting as bronchial asthma. Respiration 1991, 58: 329-331.
4.
El-Kassimi FA,
Abdullah AK, Al-Orainey IO, Bener AB, Al-Hajjaj MS.
Tuberculin survey in the Eastern
Province of Saudi Arabia. Resp Med 1991; 85: 111-116.
5.
Al-Kassimi FA,
Abdullah AK, Al-Orainey IO, Benar AB, Al-Hajjaj MS, Al-Majed S,
Al-Wazzan A. The significance of
positive Mantoux reactions in BCG-vaccinated children. Tubercle 1991;
72 (2) 101-104.
6.
Al-Kassimi FA,
Azhar M, Al-Majed S, Al-Wazzan AD, Al-Hajjaj MS, Malibary T.
Diagnostic role of fibreoptic bronchoscopy in tuberculosis in the
presence of typical X-ray pictures and adequate sputum. Tubercle 1991;
72 (2) 145-148.
7.
Al-Kassimi F,
Abdullah A, Al-Orainey IO, Al-Hajjaj MS, Abdul Baghee E, Baner A.
Mantoux reaction survey conducted in the Northern region of Saudi
Arabia. Annals of Saudi Medicine 1991; 11 (3): 315-321.
8.
Abdullah AK,
El-Kassimi FA, Al-Orainey IO, Lambourne A, Al-Hajjaj MS. Tuberculosis
epidemiology survey: Mantoux test
results from central region of Saudi Arabia. Saudi Medical Journal
1991; 2: 107-110.
9.
Al-Kassimi FA,
Abdullah AK, Al-Orainey IO, Al-Hajjaj MS, Baghee EA, Bamgboye E. High
prevalence of Tuberculin sensitivity in Non-Saudis in the Southern
Region: role of socio-geographic factors. Saudi Medical Journal 1991;
12 (4): 326-329.
10.
Al-Hajjaj MS,
Pandya L, Marie AA, Madani AZ, Al-Sharif N, Al-Majed SA.
Pulmonary tuberculosis in Saudi
Arabia: A retrospective study of 1566 patients. Annals of Saudi
Medicine 1991; 11 (4): 443-447.
11.
Al-Hajjaj MS,
El-Kassimi FA, Al-Orainey IO, Abdullah AK. Prevalence of tuberculosis
infection in the Western region of Saudi Arabia. Journal of King
Abdulaziz University – Medical Sciences, 1992; 2: 59-69.
12.
Al-Hajjaj MS,
Bamgboye EA. Attitudes and opinions of
medical staff towards computers. Compu Biol and Med; 1992; 22 (94):
221-226.
13.
Jarallah JS,
Elias AK, Al-Hajjaj MS, Bukhari MS, Al-Shareef AH, Al-Shammari SA.
High rate of rifampicin resistance of
Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle
and Lung Diseases 1992; 73: 113-115.
14.
Al-Orainey IO,
Gad El-Rab MO, Al-Hajjaj MS, Saeed ES.
Detection of Mycobacterial Antigens in Sputum by an enzyme Immunoassay.
Eur J Clin Microbiol Infect Dis. 1992; 11: 58-61.
15.
Al-Kassimi FA,
Abdullah AK, Al-Hajjaj MS, Al-Orainey IO, Bamgboye EA, Chowdhury MNH.
Nationwide community survey of
tuberculosis epidemiology in Saudi Arabia. Tubercle and Lung Disease
1993; ;74: 254-260.
16.
Al-Hajjaj MS.
The situation of tuberculosis in Saudi Arabia; An Assignment Report.
WHO project No. TUB/11/22. SAA/TUB/001, 1993.
17.
Dahmash MS, Arora
SC, Al-Hajjaj MS. Bronchoalveolar cell carcinoma associated with
profuse bronchorrhea. Med Sci Res 1994; 22: 385-386.
18.
Dahmash NS, Gad
El-Rab MO, Al-Hajjaj MS. Overwhelming
respiratory failure associated with legionella pneumophilia. Ann Saudi
Med 1994; 14 (3): 204-208.
19.
Al-Hajjaj MS,
Al-Nasser MN, Huraib SO, Al-Kassimi FA.
Effect of moderately high altitude on
the pattern of lung disease. Ann Saudi Med 1994; 14 (4): 297-299.
20.
Al-Subaie AS,
Al-Hajjaj MS. Awareness and Knowledge of Saudi students about drug
dependence. Saudi Med J 1995; 16 (4): 326-329.
21.
Al-Kassimi FA,
Al-Hajjaj MS, Al-Orainey IO, Bamgboye EA.
Does the protective effect of neonatal
BCG correlate with vaccine induced tuberculin reaction? Am J Respir
Crit Care Med 1995; 152: 1575-8.
22.
Al-Hajjaj MS.
Medical practice in Saudi Arabia, the medico-legal aspect. Saudi Med J
1996; 17 (1): 1-4.
23.
Al-Hajjaj MS,
Al-Jiffri M, Al-Dhawie O, Al-Shareef N, Ibrahim HM. Treatment of
tuberculosis as adopted by the Saudi National Control Program
Committee. Saudi Med J 1996; 17 (5): 552-557.
24.
Ashour M,
Al-Kattan KM, Jain SK, Al-Majed S, Al-Kassimi FA, Mobeireek A, Al-Hajjaj
M, Alzeer A. Surgery for Unilateral
bronchiectasis: results and prognostic factors. Tubercle and lung
disease, 1996; 77: 168-172.
25.
Al-Majed SA,
Ashour M, Al-Mobeireek AF, Al-Hajjaj MS, Alzeer AH, Al-Kattan K.
Overlooked inhaled foreign bodies:
late sequelae and the likelihood of recovery. Respiratory Medicine,
1997; 91: 293-296.
26.
Al-Hajjaj MS,
Al-Khatim IM. High rate of
non-compliance with anti-tuberculosis therapy despite a retrieval
system: a call for implementation of Directly Observed Therapy in Saudi
Arabia. International Journal of Tuberculosis and Lung Disease IUATLD,
2000, 4 (4); 345-349.
27.
Al-Hajjaj MS.
The outcome of tuberculosis treatment
after implementation of the National Tuberculosis Control Program in
Saudi Arabia. Annals of Saudi Medicine, 2000; 20 (2); 125-128.
28.
Al-Hajjaj MS,
Gad-El-Rab MO, Al-Orainey IO, Al-Kassimi FA.
Improved sensitivity for detection of
tuberculosis cases by a modified Anda-TB Elisa test. Tubercle and lung
Disease 1999; 79 (3): 181-185.
29.
Al-Hajjaj MS,
Al-Haider AK, Islam MW. Evaluation of
the Teratogenic Potential of Pyrazinamide in Wistar Rats. Upsala
Journal of Medical Science. Upsala J Med Sci, 1999; 104: 259-279.
30.
Al-Hajjaj MS,
Joharjy IA. Predictors of the
radiological sequelae of pulmonary tuberculosis. Acta Radiologica, 2000
(41); 533-537.
31.
Al-Hajjaj MS.
Case Report: Massive pulmonary
hemorrhage in a Saudi female with primary antiphospholipid syndrome.
Saudi Med Journal, 2000; 21 (8); 777-779.
32.
Al-Mobeireek A,
Al-Kassimi F, Al-Majed S, Al-Hajjaj M, BaHammam A, Sultan I.
Clinical profile of sleep apnea
syndrome. A study at the University Hospital. Saudi Med J 2000; 21
(2); 180-183.
33.
Al-Hajjaj MS.
Bronchiectasis and mediastinal
neurofibroma in a Saudi female with Ehler-Danlos Syndrome. Annals of
Saudi Medicine, 2001; 20 (5+6); 419-420.
34.
Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek
AF. Alzeer AH. Progressive Rise of
Mycobacterium Tuberculosis Resistance to Rifampicin and Streptomycin in
the Riyadh Region, Saudi Arabia. Respirology 2001; 6(3/4).
35.
Hamdan H.
Al-Jahdali, Mohamed S. Al-Hajjaj, Mohammed O. Alanezi, Mohamed O.
Zeitoni, Turki H. Al-Tasan. Asthma control assessment using asthma
control test among patients attending 5 tertiary care hospitals in Saudi
Arabia. Saudi Medical Journal 2008; Vol. 29 (5): 714-717
36.
Al-Anezi MO, Al-Hajjaj M, Al-Jahdali HH, Zeitouni MO, Al-Tasan TH,
Level of acceptance of “Asthma Control Test” among asthmatic patients in
Saudi Arabia. ( submitted).
37.
Al-Hajjaj
MS. Bronchial asthma in developing countries: A major social and
economic burden. Ann Thorac Med 2008;3:39-40.
ABSTRACTS
APPEARED IN PROCEEDINGS OF SYMPOSIA AND CONFERENCES:
1.
Al-Kassimi FA,
Abdullah AK, Al-Hajjaj MS, Al-Orainey Io. Tuberculosis epidemiology in
the Western Region of Saudi Arabia. British Thoracic Society Meeting.
University of Southampton, England; 12-14 July 1989. Proceedings of the
British Thoracic Society Meeting, Thorax 1989; 44 (10): p. 869p.
2.
Waheed G, Yaqub
B, Al-Majed S, Al-Hajjaj M. Polysomnographic recording of sleep apnea
syndrome by video. Recent Advances in clinical neurosciences
symposium. Jeddah, November 1989. Proceedings of the symposium p 34.
3.
Al-Hajjaj MS,
El-Kassimi F, Al-Orainey I, Abdulla A. Prevalence of tuberculosis
infection in the Northern region of Saudi Arabia. World Conference on
Lung Health, Boston May 1990. American Review of Respiratory Diseases
supplement April 1990. p A801.
4.
Al-Hajjaj M.
Prevalence of tuberculosis infection in the Southern Region of Saudi
Arabia. Endemic Diseases Symposium, Al-Baha, Saudi Arabia, January
1990.
5.
Al-Hajjaj M.
Immunology of Tuberculosis. Symposium on Basic immunology in Clinical
medicine. King Saud University, Medical College. Riyadh, Saudi
Arabia. March, 1990. Proceedings of the symposium p. 11.
6.
Al-Hajjaj MS, Xie
HJ, Enarson DA, Allen EA, Grzybowski S. Serious drug toxicity in
tuberculosis treatment programs. World Conference on Lung Health,
Boston, May 1990. American Review of Respiratory Diseases supplement
April 1990. p. A441.
7.
Al-Kassimi FA,
Al-Hajjaj MS, Al-Orainey IO, Bener AB. Significance of positive Mantoux
reaction in BCG vaccinated children. International Conference on
Immunization and Immunotherapy. King Fahad Hospital for National
Guards, Riyadh, Saudi Arabia; January 27-30, 1990. Proceedings of the
symposium p. 60.
8.
Al-Hajjaj MS,
Allergic broncho-pulmonary aspergillosis (ABPA). Symposium on diagnosis
and management of respiratory allergic disorders. Taif, April 1993.
9.
Al-Hajjaj MS.
Current situation of tuberculosis in Saudi Arabia. Symposium on
tuberculosis. Dammam, January 1993.
10.
Al-Subaie AS,
Al-Hajjaj MS. Awareness and knowledge of Saudi University students
about drug dependence. Drugs Symposiusm Jeddah, Saudi Arabia, 1994.
11.
Al-Hajjaj MS,
Al-Kassimi FA, Al-Orainey IO, Johargy I. The Radiological Sequelae of
Pulmonary Tuberculosis: can they be prevented? Conference on Global
Lung Health and the 1997 Annual Meeting of the IUATLD. Paris, France.
1-4 October 1997.
12.
Al-Hajjaj MS,
Al-Sawaf H. Predictive Factors of Poor Lung Function in Cured
Tuberculosis Patients. Conference on Global Lung Health and Conference
on Global Lung Health and the 1997 Annual Meeting of the IUATLD. Paris,
France. 1-4 October 1997.
13.
Al-Hajjaj MS,
Al-Orainey IO, Al-Kassimi FA, Al-Majed SA, Gad-El-Rab MO. Improved
Sensitivity for Detection in Tuberculosis Cases by a Modified ANDA TB
Serology Test. Conference on Global Lung Health and the 1997 Annual
Meeting of the IUATLD. Paris, France. 1-4 October 1997.
14.
Al-Hajjaj MS,
Al-Haider AK, Islam MW. Evaluation of the Teratogenic Potential of
Pyrazinamide in Wistar Rats. Conference on Global Lung Health and the
1997 Annual Meeting of the IUATLD. Paris, France. 1-4 October 1997.
15.
Mobeireek A,
Al-Kassimi F, Al-Majed S, Al-Hajjaj MS, Marzouk A. Diffuse Interstitial
Lung Disease (ILD): Problems with Diagnosis and Management at a
University Hospital. Chest 1999. Chicago, Illinois – USA. October 31
– 4 November 1999.
16.
Al-Hajjaj MS,
Al-Kassimi FA, Al-Orainey IO, Joharjy IA. Predictors of the
Radiological Sequelae of Pulmonary Tuberculosis. International
Symposium Pulmonary and Critical Care Medicine, King Fahad National
Guard Hospital, Riyadh, Saudi Arabia. 23-24 February 1999.
17.
Al-Hajjaj MS,
Mohamed AI. High Rate of Non-Compliance with Anti-Tuberculosis Therapy
Despite a Retrieval System: A Call for Implementation of Directly
Observed Therapy in Saudi Arabia. 15th Asia Pacific Congress
on Diseases of the Chest. Manila, Philippines. 5-8 December 1999.
18.
Al-Hajjaj MS,
Al-Haider AK, Islam MW. Evaluation of the teratogenic potential of
Pyrazinamide in Wistar Rats. 15th Asia Pacific Congress on
Diseases of the Chest. Manila, Philippines. 5-8 December 1999.
19.
Al-Hajjaj MS,
Al-Haider AK, Islam MW. Evaluation of the Teratogenic Potential of
Pyrazinamide in Wistar Rats. Chest 1999. Chicago, Illinois – USA. 31
Oct. – 4 Nov. 1999.
20.
Al-Hajjaj MS,
Al-Khatim IM. High Rate of Non-Compliance with Anti-Tuberculosis
Therapy Despite A Retrieval System: A Call for Implementation of Direct
Observed Therapy in Saudi Arabia. Tuberculosis the present and the
future. Taif, Saudi Arabia. April 19, 2000.
21.
Al-Hajjaj MS,
Al-Kassimi FA, Alzeer AH. Anti-tuberculosis drug resistance in Saudi
Arabia. The 4th Pan Arab Conference of the Arab Thoracic
Society. Dubai, UAE, Nov. 4-7, 2000.
LETTERS TO THE EDITOR:
1.
Al-Kassimi FA,
Al-Hajjaj MS, Al-Orainey IO, Bamgboye EA. Does the protective effect of
neonatal BCG correlate with vaccine-induced tuberculin reactions? Am J
Respir Crit Care Med 1996; 152: 1575-1578.
2.
Al-Hajjaj MS.
Predictive factors of poor lung function in cured tuberculosis
patients. Annals of Saudi Medicine, 2000.
ONGOING RESEARCH:
1.
Saline irrigation
and bronchoalveolar lavage for patients with bronchiectasis.
2.
Efficacy of
influenza vaccine during Haj period.
3.
Bronchoscopy in a
large teaching hospital
4.
COPD:
epidemiology and pattern in the outpatient clinic.
5.
Asthma genetic
study in Saudi population.
6.
Pulmonary
hypertension and response to treatment
7.
Kassimi FA,
Al-Hajjaj MS, Al-Hamad E et al . Role of broncchial biobsy in
differentiating asthma from COPD in smokers.
8.
Al-Hajjaj MS,
Alanezi MO, Al-Jahdlai HH
et.al
Spirometric standard measurements for healthy lifetime non-smoking
adults in Saudi Arabia. A multi-center research project sponsored by
KACST
|
